The tweet was deleted by the author.
But we saved everything 🙂.
Innovative pharmaceuticals are challenging long-held assumptions about the nature of scientific advancement.
Noubar Afeyan drew attention to a recent report from the New York Times, which examines how a newly developed drug is altering conventional wisdom in the field. Afeyan underscored the idea that substantial scientific breakthroughs are frequently rooted in notions that were initially dismissed as unattainable. He also pointed to the importance of federally funded basic research in powering discoveries. The developments described further raise questions about the dynamics and value of public investment in driving innovation.